

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of other organism (GO:0098543) | 5.27524873 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.12842793 |
| 3 | response to peptidoglycan (GO:0032494) | 5.06911589 |
| 4 | detection of bacterium (GO:0016045) | 5.04803761 |
| 5 | detection of external biotic stimulus (GO:0098581) | 4.61127348 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 4.42775644 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38694979 |
| 8 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.26638120 |
| 9 | detection of biotic stimulus (GO:0009595) | 4.21329275 |
| 10 | positive regulation of mast cell activation (GO:0033005) | 4.17153692 |
| 11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15015189 |
| 12 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.99536470 |
| 13 | positive regulation of mast cell degranulation (GO:0043306) | 3.99536470 |
| 14 | regulation of mast cell activation (GO:0033003) | 3.82850804 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 3.82482589 |
| 16 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.72232006 |
| 17 | neutrophil activation (GO:0042119) | 3.69680938 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67063140 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.67063140 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67063140 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67063140 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67063140 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.67063140 |
| 24 | myeloid cell activation involved in immune response (GO:0002275) | 3.47919984 |
| 25 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46719273 |
| 26 | microglial cell activation (GO:0001774) | 3.46356599 |
| 27 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.45805701 |
| 28 | cellular extravasation (GO:0045123) | 3.45560273 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.42272107 |
| 30 | granulocyte activation (GO:0036230) | 3.39813418 |
| 31 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.39423787 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38834259 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38105762 |
| 34 | neutrophil mediated immunity (GO:0002446) | 3.33208554 |
| 35 | regulation of hypersensitivity (GO:0002883) | 3.33101307 |
| 36 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.22749011 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.21616821 |
| 38 | macrophage activation (GO:0042116) | 3.21210526 |
| 39 | negative regulation of interleukin-17 production (GO:0032700) | 3.15519815 |
| 40 | positive regulation of macrophage cytokine production (GO:0060907) | 3.14070186 |
| 41 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.14021006 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.13696783 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13314674 |
| 44 | leukocyte degranulation (GO:0043299) | 3.11258328 |
| 45 | positive regulation of leukocyte degranulation (GO:0043302) | 3.06666902 |
| 46 | sphingosine metabolic process (GO:0006670) | 3.03297140 |
| 47 | regulation of macrophage cytokine production (GO:0010935) | 3.02619636 |
| 48 | regulation of mononuclear cell migration (GO:0071675) | 2.95084014 |
| 49 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.93112985 |
| 50 | regulation of interleukin-8 secretion (GO:2000482) | 2.93013045 |
| 51 | defense response to protozoan (GO:0042832) | 2.92824935 |
| 52 | mast cell activation (GO:0045576) | 2.89561746 |
| 53 | positive thymic T cell selection (GO:0045059) | 2.86805832 |
| 54 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.86521205 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85554825 |
| 56 | response to host immune response (GO:0052572) | 2.85554825 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85266407 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 2.84182361 |
| 59 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.83583602 |
| 60 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.81649814 |
| 61 | positive regulation of interleukin-10 production (GO:0032733) | 2.79778115 |
| 62 | negative regulation of mast cell activation (GO:0033004) | 2.79125185 |
| 63 | positive regulation of interleukin-6 production (GO:0032755) | 2.78734122 |
| 64 | mast cell degranulation (GO:0043303) | 2.77713000 |
| 65 | mast cell activation involved in immune response (GO:0002279) | 2.77713000 |
| 66 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75875018 |
| 67 | response to xenobiotic stimulus (GO:0009410) | 2.74743643 |
| 68 | negative thymic T cell selection (GO:0045060) | 2.73508673 |
| 69 | response to protozoan (GO:0001562) | 2.70679658 |
| 70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.68959626 |
| 71 | response to hydroperoxide (GO:0033194) | 2.67238539 |
| 72 | regulation of monocyte chemotaxis (GO:0090025) | 2.66321836 |
| 73 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.66318517 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 2.65734271 |
| 75 | T-helper 1 type immune response (GO:0042088) | 2.65283865 |
| 76 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.65052266 |
| 77 | myeloid leukocyte mediated immunity (GO:0002444) | 2.64275474 |
| 78 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.64145658 |
| 79 | melanin metabolic process (GO:0006582) | 2.62868805 |
| 80 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.62112176 |
| 81 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.59977773 |
| 82 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.56849198 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 2.56649880 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.56380243 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56250024 |
| 86 | superoxide anion generation (GO:0042554) | 2.55519939 |
| 87 | myeloid leukocyte activation (GO:0002274) | 2.55057176 |
| 88 | endothelium development (GO:0003158) | 2.54657210 |
| 89 | B cell receptor signaling pathway (GO:0050853) | 2.54565130 |
| 90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54564195 |
| 91 | melanin biosynthetic process (GO:0042438) | 2.52364145 |
| 92 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51503240 |
| 93 | positive regulation of type 2 immune response (GO:0002830) | 2.50906329 |
| 94 | diol metabolic process (GO:0034311) | 2.49453463 |
| 95 | cell wall macromolecule metabolic process (GO:0044036) | 2.49092524 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 2.47286878 |
| 97 | amine catabolic process (GO:0009310) | 2.47286878 |
| 98 | positive regulation of vasculogenesis (GO:2001214) | 2.47269930 |
| 99 | lymphoid progenitor cell differentiation (GO:0002320) | 2.47171900 |
| 100 | oligosaccharide catabolic process (GO:0009313) | 2.45193362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.27396449 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.15501905 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.87808524 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.22702938 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97172558 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.96838943 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93041131 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90655637 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.88545516 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.82664679 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61591634 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56582466 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52751489 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50229214 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.35651532 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.34327324 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.22915871 |
| 18 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.16613498 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14220250 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12723067 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12549760 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.08533364 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94276475 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90824643 |
| 25 | GATA3_26560356_Chip-Seq_TH2_Human | 1.87523820 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83960658 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.80963043 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.79086909 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76391759 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74797192 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66239917 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64936982 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63410565 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58968049 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53156673 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52077585 |
| 37 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47434410 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38516867 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37562160 |
| 40 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37067117 |
| 41 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32255893 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28954580 |
| 43 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.27965287 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27705943 |
| 45 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.24720395 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24559746 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24019487 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23953946 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23651926 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19818417 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17242233 |
| 52 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16351296 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15126288 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12704876 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12143722 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11416760 |
| 57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10541870 |
| 58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10541870 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09134688 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09121604 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07345419 |
| 62 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07075313 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05915121 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05849782 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05617245 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04108162 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03373519 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02965284 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02965284 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00527239 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00261672 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00109031 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99100598 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98998675 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98400184 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97699836 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97192331 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 0.96148473 |
| 79 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95628034 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95144681 |
| 81 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94947381 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93056480 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92655290 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91866543 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91707242 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91570444 |
| 87 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91423860 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91268971 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89475911 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.89106949 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88846071 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87905118 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87429665 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87228967 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87025124 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86959016 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86836824 |
| 98 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86664153 |
| 99 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86077106 |
| 100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85389578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.56007426 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.37644548 |
| 3 | MP0000372_irregular_coat_pigmentation | 3.29988838 |
| 4 | MP0003283_abnormal_digestive_organ | 2.97614897 |
| 5 | MP0003303_peritoneal_inflammation | 2.86004004 |
| 6 | MP0005464_abnormal_platelet_physiology | 2.77331578 |
| 7 | MP0003195_calcinosis | 2.76800186 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.55045882 |
| 9 | MP0002419_abnormal_innate_immunity | 2.49822132 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.47679904 |
| 11 | MP0009785_altered_susceptibility_to | 2.44458540 |
| 12 | MP0003436_decreased_susceptibility_to | 2.39813570 |
| 13 | MP0005171_absent_coat_pigmentation | 2.37654587 |
| 14 | MP0006082_CNS_inflammation | 2.34557305 |
| 15 | MP0002102_abnormal_ear_morphology | 2.33942634 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.32450864 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.31991124 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 2.31991124 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.24004037 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.22876862 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.05312775 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.03857220 |
| 23 | MP0005387_immune_system_phenotype | 2.03136224 |
| 24 | MP0001790_abnormal_immune_system | 2.03136224 |
| 25 | MP0005671_abnormal_response_to | 2.01744139 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.99850189 |
| 27 | MP0000371_diluted_coat_color | 1.90430182 |
| 28 | MP0000685_abnormal_immune_system | 1.88879159 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.88164998 |
| 30 | MP0009764_decreased_sensitivity_to | 1.84434452 |
| 31 | MP0005025_abnormal_response_to | 1.84343583 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.83714012 |
| 33 | MP0004381_abnormal_hair_follicle | 1.81794885 |
| 34 | MP0002723_abnormal_immune_serum | 1.77723146 |
| 35 | MP0001800_abnormal_humoral_immune | 1.74912812 |
| 36 | MP0005408_hypopigmentation | 1.67303426 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.65499236 |
| 38 | MP0009278_abnormal_bone_marrow | 1.60990777 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.58842673 |
| 40 | MP0001819_abnormal_immune_cell | 1.56619346 |
| 41 | MP0000343_altered_response_to | 1.55975231 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.55740966 |
| 43 | MP0008260_abnormal_autophagy | 1.49937916 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.49438675 |
| 45 | MP0002095_abnormal_skin_pigmentation | 1.46904972 |
| 46 | MP0003075_altered_response_to | 1.44242371 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.43128267 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.41621747 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.39599740 |
| 50 | MP0001851_eye_inflammation | 1.32041987 |
| 51 | MP0009765_abnormal_xenobiotic_induced | 1.26014147 |
| 52 | MP0003828_pulmonary_edema | 1.24822737 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.24449234 |
| 54 | MP0009763_increased_sensitivity_to | 1.20135877 |
| 55 | MP0008469_abnormal_protein_level | 1.19197574 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.14803368 |
| 57 | MP0000716_abnormal_immune_system | 1.13305951 |
| 58 | MP0000383_abnormal_hair_follicle | 1.12121473 |
| 59 | MP0002405_respiratory_system_inflammati | 1.08753963 |
| 60 | MP0003136_yellow_coat_color | 1.08243652 |
| 61 | MP0005670_abnormal_white_adipose | 1.08166887 |
| 62 | MP0001853_heart_inflammation | 1.05632225 |
| 63 | MP0002398_abnormal_bone_marrow | 1.03622366 |
| 64 | MP0002822_catalepsy | 1.01256799 |
| 65 | MP0003866_abnormal_defecation | 1.00197417 |
| 66 | MP0000689_abnormal_spleen_morphology | 0.99788332 |
| 67 | MP0000858_altered_metastatic_potential | 0.98171659 |
| 68 | MP0005166_decreased_susceptibility_to | 0.98126446 |
| 69 | MP0004883_abnormal_blood_vessel | 0.97912123 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.94939467 |
| 71 | MP0004947_skin_inflammation | 0.91171570 |
| 72 | MP0003186_abnormal_redox_activity | 0.91051471 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.91004341 |
| 74 | MP0005310_abnormal_salivary_gland | 0.91003510 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.90510880 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.88793493 |
| 77 | MP0002429_abnormal_blood_cell | 0.88529645 |
| 78 | MP0002075_abnormal_coat/hair_pigmentati | 0.85773133 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 0.85635262 |
| 80 | MP0004510_myositis | 0.85019183 |
| 81 | MP0005164_abnormal_response_to | 0.83875170 |
| 82 | MP0010678_abnormal_skin_adnexa | 0.82727642 |
| 83 | MP0003646_muscle_fatigue | 0.82491933 |
| 84 | MP0010155_abnormal_intestine_physiology | 0.81819135 |
| 85 | MP0005451_abnormal_body_composition | 0.81734587 |
| 86 | MP0002722_abnormal_immune_system | 0.81559832 |
| 87 | MP0008004_abnormal_stomach_pH | 0.81236239 |
| 88 | MP0005165_increased_susceptibility_to | 0.80405894 |
| 89 | MP0002132_abnormal_respiratory_system | 0.77880603 |
| 90 | MP0009840_abnormal_foam_cell | 0.77034916 |
| 91 | MP0005647_abnormal_sex_gland | 0.75980369 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 0.72547632 |
| 93 | MP0006054_spinal_hemorrhage | 0.70805081 |
| 94 | MP0002006_tumorigenesis | 0.70530025 |
| 95 | MP0003045_fibrosis | 0.69047109 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.66115597 |
| 97 | MP0001324_abnormal_eye_pigmentation | 0.65875594 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.64819534 |
| 99 | MP0001186_pigmentation_phenotype | 0.64636953 |
| 100 | MP0000249_abnormal_blood_vessel | 0.64246622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.08338619 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 4.08338619 |
| 3 | Hyperalaninemia (HP:0003348) | 4.08338619 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.93629707 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.93629707 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.93629707 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86840606 |
| 8 | Petechiae (HP:0000967) | 3.82217257 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.73830850 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.64407675 |
| 11 | White forelock (HP:0002211) | 3.56650059 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.55787011 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.55224778 |
| 14 | Gingival bleeding (HP:0000225) | 3.50076166 |
| 15 | Prolonged bleeding time (HP:0003010) | 3.49131859 |
| 16 | Patchy hypopigmentation of hair (HP:0011365) | 3.44188129 |
| 17 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.37433255 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34685876 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34685876 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.27386817 |
| 21 | Recurrent skin infections (HP:0001581) | 3.27371824 |
| 22 | Stomatitis (HP:0010280) | 3.20824525 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.20543300 |
| 24 | Myositis (HP:0100614) | 3.16256873 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.03913692 |
| 26 | Orchitis (HP:0100796) | 2.99825676 |
| 27 | Congenital sensorineural hearing impairment (HP:0008527) | 2.98772391 |
| 28 | Epistaxis (HP:0000421) | 2.93824749 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91956940 |
| 30 | Recurrent fungal infections (HP:0002841) | 2.90516944 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.86609822 |
| 32 | Encephalitis (HP:0002383) | 2.85402425 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.84081352 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.79878566 |
| 35 | Optic neuritis (HP:0100653) | 2.79878566 |
| 36 | Purpura (HP:0000979) | 2.72611053 |
| 37 | Episodic fever (HP:0001954) | 2.72226353 |
| 38 | Increased IgE level (HP:0003212) | 2.65610023 |
| 39 | Hypoplasia of the fovea (HP:0007750) | 2.65373223 |
| 40 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.65373223 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 2.62531499 |
| 42 | Loss of speech (HP:0002371) | 2.60314659 |
| 43 | Acute hepatic failure (HP:0006554) | 2.56088842 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.54095645 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.52337535 |
| 46 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.51038356 |
| 47 | Dyschromatopsia (HP:0007641) | 2.50215246 |
| 48 | Alopecia of scalp (HP:0002293) | 2.44437511 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42048168 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42048168 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42048168 |
| 52 | Abnormality of the fovea (HP:0000493) | 2.36237391 |
| 53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.35396296 |
| 54 | Autoimmune thrombocytopenia (HP:0001973) | 2.32279338 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.31462883 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.31210920 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.29858160 |
| 58 | Urticaria (HP:0001025) | 2.28272263 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.27236987 |
| 60 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.25604690 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24910968 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.24910968 |
| 63 | Meningitis (HP:0001287) | 2.24709899 |
| 64 | Severe visual impairment (HP:0001141) | 2.23882319 |
| 65 | Amyloidosis (HP:0011034) | 2.22933450 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.21949292 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.21690475 |
| 68 | Gangrene (HP:0100758) | 2.20598579 |
| 69 | Vasculitis (HP:0002633) | 2.19101839 |
| 70 | Obstructive lung disease (HP:0006536) | 2.18009124 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18009124 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.16340382 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.16098938 |
| 74 | Acanthocytosis (HP:0001927) | 2.13603829 |
| 75 | Recurrent viral infections (HP:0004429) | 2.12993670 |
| 76 | Chest pain (HP:0100749) | 2.09727548 |
| 77 | Albinism (HP:0001022) | 2.06624931 |
| 78 | Central scotoma (HP:0000603) | 2.06290875 |
| 79 | Abnormal auditory evoked potentials (HP:0006958) | 2.03389457 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.03333773 |
| 81 | 3-Methylglutaconic aciduria (HP:0003535) | 2.03333018 |
| 82 | Increased mean platelet volume (HP:0011877) | 2.03068384 |
| 83 | Menorrhagia (HP:0000132) | 2.02227084 |
| 84 | Myocardial infarction (HP:0001658) | 2.01886137 |
| 85 | Nausea (HP:0002018) | 1.99533150 |
| 86 | Arterial thrombosis (HP:0004420) | 1.98660521 |
| 87 | Blue irides (HP:0000635) | 1.98053042 |
| 88 | Disinhibition (HP:0000734) | 1.96592847 |
| 89 | Generalized hypopigmentation (HP:0007513) | 1.95335284 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 1.94988119 |
| 91 | Joint swelling (HP:0001386) | 1.94906392 |
| 92 | Parakeratosis (HP:0001036) | 1.91260331 |
| 93 | Keratitis (HP:0000491) | 1.91258240 |
| 94 | Viral hepatitis (HP:0006562) | 1.90975731 |
| 95 | Colitis (HP:0002583) | 1.89410079 |
| 96 | Fatigue (HP:0012378) | 1.87489080 |
| 97 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87034080 |
| 98 | Vertigo (HP:0002321) | 1.85182984 |
| 99 | Submucous cleft hard palate (HP:0000176) | 1.82131896 |
| 100 | Inflammation of the large intestine (HP:0002037) | 1.82048740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 3.56299765 |
| 2 | RIPK4 | 3.11103976 |
| 3 | TAOK3 | 2.80189293 |
| 4 | BLK | 2.48616682 |
| 5 | MAP2K3 | 2.40942470 |
| 6 | ACVR1B | 2.24759335 |
| 7 | ERBB3 | 2.23819352 |
| 8 | SIK3 | 1.94954616 |
| 9 | MAP3K12 | 1.91031233 |
| 10 | KIT | 1.87181711 |
| 11 | INSRR | 1.86904691 |
| 12 | IRAK4 | 1.86091968 |
| 13 | TEC | 1.84846976 |
| 14 | FRK | 1.73147024 |
| 15 | CSF1R | 1.70816466 |
| 16 | TRPM7 | 1.65321574 |
| 17 | BMPR1B | 1.57164199 |
| 18 | ZAP70 | 1.53148621 |
| 19 | SYK | 1.52424676 |
| 20 | TYK2 | 1.48802099 |
| 21 | STK10 | 1.48370400 |
| 22 | IRAK2 | 1.46651429 |
| 23 | CSK | 1.46035560 |
| 24 | MAP3K3 | 1.45977909 |
| 25 | GRK7 | 1.45401815 |
| 26 | TGFBR2 | 1.40728710 |
| 27 | FER | 1.39362184 |
| 28 | BTK | 1.39115942 |
| 29 | FLT3 | 1.34966566 |
| 30 | MAP3K6 | 1.33003396 |
| 31 | BMPR2 | 1.31298455 |
| 32 | HCK | 1.30898727 |
| 33 | IKBKB | 1.30161752 |
| 34 | IRAK1 | 1.29078597 |
| 35 | FGR | 1.27931371 |
| 36 | MAP3K14 | 1.22598204 |
| 37 | TXK | 1.22304448 |
| 38 | MAP3K5 | 1.22280109 |
| 39 | MARK3 | 1.20200331 |
| 40 | YES1 | 1.19112067 |
| 41 | PTK2B | 1.18249538 |
| 42 | MAP4K1 | 1.15936430 |
| 43 | JAK3 | 1.14965271 |
| 44 | CCNB1 | 1.13444539 |
| 45 | LYN | 1.09435853 |
| 46 | TBK1 | 1.07554813 |
| 47 | MATK | 1.07442271 |
| 48 | MAP2K6 | 1.01615541 |
| 49 | FES | 1.00420440 |
| 50 | ITK | 0.99286951 |
| 51 | PINK1 | 0.97174134 |
| 52 | TNK2 | 0.91035785 |
| 53 | PIK3CG | 0.90998743 |
| 54 | KDR | 0.90940643 |
| 55 | IKBKE | 0.88078097 |
| 56 | IRAK3 | 0.87331231 |
| 57 | PIM2 | 0.85359333 |
| 58 | GRK6 | 0.84926735 |
| 59 | MAPK13 | 0.83398725 |
| 60 | MAP4K2 | 0.83138861 |
| 61 | TESK2 | 0.81833927 |
| 62 | ERN1 | 0.80524076 |
| 63 | MAP3K11 | 0.75242893 |
| 64 | PRKD1 | 0.75125691 |
| 65 | NEK9 | 0.70817936 |
| 66 | TRIM28 | 0.70155360 |
| 67 | STK24 | 0.69513551 |
| 68 | ADRBK2 | 0.68793592 |
| 69 | MAP3K1 | 0.67415713 |
| 70 | STK16 | 0.66230549 |
| 71 | IGF1R | 0.65358030 |
| 72 | LCK | 0.64962578 |
| 73 | PDK1 | 0.64939227 |
| 74 | JAK2 | 0.63260503 |
| 75 | MAPK12 | 0.62683701 |
| 76 | STK3 | 0.61402746 |
| 77 | PRKD2 | 0.61235888 |
| 78 | PKN1 | 0.59452474 |
| 79 | PLK2 | 0.57442133 |
| 80 | ABL2 | 0.56136074 |
| 81 | ABL1 | 0.55889012 |
| 82 | PIM1 | 0.55279098 |
| 83 | CSNK1G2 | 0.54738943 |
| 84 | MYLK | 0.54682705 |
| 85 | MST4 | 0.54630545 |
| 86 | CDK8 | 0.51458141 |
| 87 | DAPK2 | 0.50318500 |
| 88 | CHUK | 0.49039349 |
| 89 | PAK3 | 0.48265347 |
| 90 | JAK1 | 0.48096892 |
| 91 | TGFBR1 | 0.44819910 |
| 92 | PLK4 | 0.44743209 |
| 93 | PRKCE | 0.43769265 |
| 94 | PRKD3 | 0.43760777 |
| 95 | PDPK1 | 0.43487130 |
| 96 | MAP3K2 | 0.43391960 |
| 97 | CSNK1G3 | 0.43036060 |
| 98 | ADRBK1 | 0.40819088 |
| 99 | DYRK1B | 0.40465390 |
| 100 | STK38L | 0.40224147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91141188 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71044094 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.61770468 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.51962453 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40739767 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.35003869 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.33047475 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26475326 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.26214698 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25170467 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.25049758 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 2.18143648 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15560394 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.14403289 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09303736 |
| 16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.08656451 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.05674366 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.03055468 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.01688228 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 2.00638685 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97208611 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94398404 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69778759 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.69338264 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.57382052 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.55850587 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.47718462 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.43251349 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.42873348 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38701755 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27435995 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19830529 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15316911 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.15181744 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.14002847 |
| 36 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.13433548 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11278550 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09713550 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.08616920 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07333086 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07050542 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04904359 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03896876 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01830442 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98892005 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98467398 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95833123 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93532462 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93262999 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.90096225 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89946866 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89411185 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87325024 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86265058 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85029700 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83893051 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.83620624 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82661322 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82637497 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.79427100 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75167891 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71967411 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71172122 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70512928 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70346639 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65262889 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.60604720 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58860297 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58359649 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57878414 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57481384 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56057338 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.53536950 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52182477 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50764701 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47946243 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45190067 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45106905 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43129094 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.42943152 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42838980 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41260006 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.41136020 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40425596 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40000039 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.37683984 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37132845 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36611515 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35877528 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34672059 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34543355 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33909724 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33427677 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30220351 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27806694 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26386702 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.26193457 |
| 98 | Phototransduction_Homo sapiens_hsa04744 | 0.24199136 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23911177 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23704360 |

